One Small Step or One Giant Leap Towards Access to Medicines For All
In December 2005, the World Trade Organisation members amended the Trade Related Aspects of Intellectual Property Rights agreement to find a solution to the problem of access to medicine. However, intellectual property provisions, as delineated in bilateral and regional free trade agreements, have the potential to undermine their purpose and success.
2. www.unaids.org Geneva: The Joint United Nations Programme on HIV/AIDS (“UNAIDS”). [Nov 2007] 2007 AIDS epidemic update. Available from: http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/200 7/
3. Attarn, A, Gillespie-White, L. Do Patents for Antiretrovial Drugs Constrain Access to AIDS Treatment in Africa? Journal of the American Medical Association 2001 [reprinted Oct 17, 2001]; 286 (15): 1886-92.
4.Abbott, FM, The Doha Declaration on the TRIPS Agreement and Public Health: Lighting a dark corner. Journal of International Economic Law 2002; 5 (2):469-505. 5. Correa CM. Implications of the Doha Declaration on the TRIPS Agreement and Public Health. Health Economics and Drugs EDM Series. 2002;12 WHO/EDM/PAR/2002.3.
6. Oxfam Ireland. Dublin: Oxfam International; [27 November 2007] Pharmaceutical industry is undermining its own future as millions of poor people denied access to medicines. Available from: http://www.oxfamireland.org/news/releases/2007/11_27.shtml
7. Attaran A. How do patents and economic policies affect access to essential medicines in developing countries? Health Aff 2004; 23:155–66.
8. Cohen, et Al. TRIPS, the Doha Declaration and increasing access to medicines: policy options for Ghana. Globalization and Health 2005, 1:17[9 December 2005] Available from: http://www.globalizationandhealth.com/content/1/1/17
9. www.ustr.gov Office of the United States Trade Representative. Washington DC. [Sept 14, 2004] Available from: http://www.ustr.gov/Document_Library/Fact_Sheets/2004/US- Bahrain_FTA_Fact_Sheet_on_Access_to_Medicines.html
10. Mercurio B, TRIPS-Plus Provisions in FTAs: Recent Trends, Lorand B, Ortino, F, editors. Regional Trade Agreements and the WTO Legal System, Oxford University Press. 2006; 221-2.
11. Correa, CM. Protecting Test Data for Pharmaceutical and Agrochemical Products under Free Trade Agreements” In: Roffe, P, Tansey, G, Vivas-Eugui, D, editors. Negotiating Health: Intellectual Property and Access to Medicines. London: Earthscan; 2006. p.81-96.
12. www.ustr.gov Office of the United States Trade Representative. Washington DC. Available from: http://www.ustr.gov/assets/Document_Library/Reports_Publications/2007/2007_Spe cial_301_Review/asset_upload_file230_11122.pdf?ht=
13. www.clintonfoundation.org New York: William J. Clinton Foundation; ©2004- 2008 Clinton Foundation [May 8, 2007] Clinton Foundation and UNITAID Announce Price Reductions on 16 AIDS Medicines for 66 Developing Countries. Available from: http://www.clintonfoundation.org/050807-nr-cf-hs-ai-pr-clinton-foundation-and- unitaid-announce-price-reductions-on-16-aids-medicines-for-66-developing-countrie s.htm
14. Gerhardsen, Tove Iren S. Intellectual Property Watch. [26 October 2006] Way Sought To Boost Developing Country Production Of Essential Medicines. Available from: http://www.ip-watch.org/weblog/index.php?p=433
How to Cite
Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
Provided they are the owners of the copyright to their work, authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository, in a journal or publish it in a book), with an acknowledgement of its initial publication in this journal.